40 results
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
Diabetes Type 2 ... Medication Management ... Established ASCVD or CKD ... #Diabetes #DM2 ... #Algorithm #endocrinology
Diabetes – diabetic nephropathy
Majority of the literature in the area is applied to the diabetic nephropathy
Diabetesdiabetic ... applied to the diabetic ... primary cause of diabetic ... - Cytokines #Pathophysiology ... #Nephrology #CKD
Pathogenesis and Pathophysiology of Diabetic Ketoacidosis (DKA)

DKA is a result of an absolute or relative insulin
of Diabetic Ketoacidosis ... of carbohydrate metabolism ... state and fat metabolism ... #Pathophysiology ... #Endocrinology
Complications of CKD
 - Patients with stages 1-3 ([GFR] >30 mL/min) of CKD are generally asymptomatic;
Complications of CKD ... >30 mL/min) of CKD ... imbalances or endocrine/metabolic ... #Pathophysiology ... #Nephrology #CKD
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Improved outcomes in CKD ... EricsMedicalLectures/featured #diabetes ... table #comparison #management ... #endocrinology
Diabetic Myonecrosis (Diabetic Muscle Infarction)
 • Spontaneous ischemic necrosis of skeletal muscle (anterior thigh or calf)
(Diabetic Muscle ... muscle (anterior thigh ... Common pattern: ↑CK ... treatment • High ... Infarction #diagnosis #management
High Anion Gap Metabolic Acidosis (HAGMA) - Differential Diagnosis - GOLDMARK

Glycols - ethylene and propylene glycol
Oxoproline
High Anion Gap Metabolic ... during hypoxic metabolism ... Ketoacidosis - diabetic ... #Anion #Gap #Metabolic ... GOLDMARK #mnemonic #nephrology
Hypocalcemia - Diagnosis and Management
PTH Independent (↑ PTH)
 • LOW VIT D
    -
Diagnosis and Management ... Kidney Disease (CKD ... ) - Metabolism ... Hypocalcemia #Diagnosis #Management ... #endocrinology
Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH
Euglycemic Diabetic ... Definition of EuDKA • Metabolic ... level < 200 mg/dL Pathophysiology ... EuDKA #diagnosis #management ... #endocrinology
Guidelines for the management of fractures in CKD

#fractures #management #ckd #nephrology #pth #endocrinology
Guidelines for the management ... of fractures in CKD ... #fractures #management ... #ckd #nephrology ... #pth #endocrinology